North America PACS and RIS Market to Grow at a CAGR of 8.6% to reach US$ 2,243.7 million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America PACS and RIS Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America PACS and RIS Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Affordable Price of New Generation PACS Software to Favor Market

5.2 Market Opportunities

5.2.1 Technological Advancement and Product Launches

5.3 Future Trends

5.3.1 Increasing Demand in Radiology

5.4 Impact of Drivers and Restraints

6. North America PACS and RIS Market Regional Analysis

6.1 North America PACS and RIS Market Overview

6.2 North America PACS and RIS Market Revenue 2017-2027 (US$ Million)

6.3 North America PACS and RIS Market Forecast Analysis

7. North America PACS and RIS Market Analysis – by Product

7.1 PACS

7.1.1 Overview
7.1.2 PACS: North America PACS and RIS Market – Revenue and Forecast to 2031 (US$ Million)

7.2 RIS

7.2.1 Overview
7.2.2 RIS: North America PACS and RIS Market – Revenue and Forecast to 2031 (US$ Million)

8. North America PACS and RIS Market Analysis – by Component

8.1 Hardware

8.1.1 Overview
8.1.2 Hardware: North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Software

8.2.1 Overview
8.2.2 Software: North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Services

8.3.1 Overview
8.3.2 Services: North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

9. North America PACS and RIS Market Analysis – by Deployment

9.1 Web-Based

9.1.1 Overview
9.1.2 Services: North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

9.2 On-Premise and Cloud-Based

9.2.1 Overview
9.2.2 Services: North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

10. North America PACS and RIS Market – North America Analysis

10.1 North America

10.1.1 North America PACS and RIS Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 North America PACS and RIS Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 US: North America PACS and RIS Market Breakdown, by Product
10.1.1.1.2 US: North America PACS and RIS Market Breakdown, by Component
10.1.1.1.3 US: North America PACS and RIS Market Breakdown, by Deployment

10.1.1.2 Canada: North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Canada: North America PACS and RIS Market Breakdown, by Product
10.1.1.2.2 Canada: North America PACS and RIS Market Breakdown, by Component
10.1.1.2.3 Canada: North America PACS and RIS Market Breakdown, by Deployment

10.1.1.3 Mexico : North America PACS and RIS Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 Mexico : North America PACS and RIS Market Breakdown, by Product
10.1.1.3.2 Mexico : North America PACS and RIS Market Breakdown, by Component
10.1.1.3.3 Mexico : North America PACS and RIS Market Breakdown, by Deployment

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America PACS and RIS Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Agfa-Gevaert Group

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 INFINITT Healthcare Co., Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 McKesson Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cerner Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 General Electric Company

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Koninklijke Philips N.V.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 FUJIFILM Holdings Corporation

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Siemens AG

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 IBM

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Novarad

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights